Diagnostic Center | July 27, 2022
Nuance Pharma announces the completion of dosing for all NTM-001 Phase 1 clinical study
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
The NTM-001 Phase I clinical study is expected to be completed by the end of 2022
Aarti Drugs Limited has reported total income of Rs. 622.22 crores during the quarter ended June 30, 2022.
This will not only strengthen the country’s overall position in the global vaccine industry but also reduce its reliance on foreign vaccines
The company has reported total income of Rs. 186.97 crores during the period ended June 30, 2022.
The company has reported total income of Rs. 94.30 crores during the period ended June 30, 2022.
GlaxoSmithKline Pharmaceuticals has reported total income of Rs. 772.71 crores during the period ended June 30, 2022
72.5% elderly feel their generation used to spend more time with their elders, 52.4% feel lonely, shows PAN Health’s Liberty in Life of Older People 2022 survey
Suven Life Sciences has reported total income of Rs. 3.97 crores during the period ended June 30, 2022
The product will be manufactured at Lupin's facility in Nagpur, India.
The Award reinforces Cadila’s digital initiatives which is backed by innovation, research & development and robust frameworks.
Subscribe To Our Newsletter & Stay Updated
